| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +254.5% |
| Cost of Revenue | $5.3M | +254.5% |
| Gross Profit | -$1.0M | -254.5% |
| R&D Expense | $984K | +282.1% |
| SG&A Expense | $11.1M | -35.8% |
| Operating Income | -$33.4M | -104.9% |
| Interest Expense | $372K | -73.0% |
| Income Tax | $37.4M | +54.4% |
| Net Income | -$37.4M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -52.0% |
| Short-term Investments | $102K | — |
| Accounts Receivable | $337K | +273.5% |
| Inventory | $106K | — |
| Current Assets | $4.5M | -44.6% |
| Total Assets | $9.2M | -14.9% |
| Current Liabilities | $5.4M | +9.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.5M | -179.5% |
| Capital Expenditures | $96K | +113.2% |
| Investing Cash Flow | -$1.2M | -113.5% |
| Financing Cash Flow | $17.6M | +11.4% |
| Free Cash Flow | -$20.6M | -179.1% |
| -54.4% |
| Total Liabilities |
| $5.5M |
| +2.7% |
| Stockholders' Equity | $1.8M | -66.8% |